Ivan Richards has been appointed senior director of pharmacology at Sirna Therapeutics, the company said Nov. 4.
Richards comes to Sirna from Pfizer, and prior to the merger, Pharmacia, where he was a scientist, senior fellow, and discovery team leader.
Ian Gray has been appointed head of research at Paradigm Therapeutics Singapore, a new Singapore R&D subsidiary of the Cambridge, UK-based company.
Gray comes to Paradigm Therapeutics from GlaxoSmithKline, where he was manager of molecular genetics in the company’s UK genetics research division, the company said last week.
Edward McCabe has joined the board of advisors at GeneFluidics, of Monterey Park, Calif., the company said Nov. 3.
McCabe is chair of the department of pediatrics at UCLA Medical School. He is also chair of the US Department of Health and Human Services Secretary’s Advisory Committee on Genetics, Health, and Society.
GeneFluidics said it is developing nanotechnology that electrochemically senses target analytes, and performs automated sample preparation.